- Bestsellers
- Alcoholism
- Allergy
- Alzheimers
- Anti Fungal
- Anti Viral
- Anti-Depressants
- Anti-Inflammatory
- Antibacterial
- Antibiotics
- Antiparasitic
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- COVID-19
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- HIV
- Hair Loss
- Hepatitis C Virus (HCV)
- Herbals
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Quit Smoking
- Skin Care
- Sleeping Aids
- Veterinary Medicines
- Vitamins
- Weight Loss
- Women's Health
Generic DDAVP ( Desmopressin )
DDAVP
| Active ingredient | Desmopressin (1-deamino-8-D-arginine vasopressin) |
|---|---|
| Mechanism of action | Vasopressin V1/V2 receptor agonist; increases water reabsorption and promotes platelet adhesion |
| Common dose | 10-40 ug sublingual, IV or IM (often 0.1-0.4 mg oral daily for nocturia) |
| What is it used for? | Diabetes insipidus, nocturnal enuresis, hemophilia A/B and vonWillebrand disease (bleeding disorders) |
| Important information on taking | Take on an empty stomach; adjust dose in renal impairment; monitor serum sodium; avoid high-protein meals |
| Common side effects | Headache, nausea, flushing, abdominal pain, mild hyponatremia |
| Serious risks | Hyponatremia, seizures, arrhythmias, severe fluid retention |
| Interactions | NSAIDs, thiazide diuretics, carbamazepine, SSRIs, other antidiureptics, antihypertensives |
| Contraindications | Hypersensitivity, existing hyponatremia, severe renal impairment, uncontrolled hypertension |
| Legal status | Prescription-only medication (not scheduled) |
A closer look at DDAVP and how it works
Definition, therapeutic role, and mechanism of action of DDAVP
DDAVP stands for desmopressin a synthetic analog of the hormone vasopressin. It is used to treat certain bleeding disorders and to reduce the frequency of urination at night. Therapeutically it helps control excessive bleeding in hemophilia a and von willebrand disease and it also manages nocturnal enuresis in children. The drug works by mimicking vasopressin activity in the pituitary gland to increase water reabsorption in the kidneys. This action leads to more concentrated urine and a decreased need for frequent nighttime urination. By modulating the release of factor viii and von willebrand factor it also promotes clot formation in patients with bleeding tendencies.
Key pharmacological features and clinical properties of DDAVP
DDAVP, also known as desmopressin, is a synthetic analogue of the hormone arginine vasopressin. It acts primarily on the v2 receptors in the kidneys to increase water reabsorption. By stimulating these receptors it reduces the production of concentrated urine and is used to treat certain bleeding disorders. The drug also binds to v1 receptors causing vasoconstriction and raising blood pressure in selected clinical settings. Its anti-hemophilic effect arises from enhancing the release of von willebrand factor and promoting platelet adhesion. The pharmacologic profile of DDAVP includes a longer half-life and greater selectivity for v2 receptors compared with native vasopressin. These properties enable therapeutic control of nocturnal enuresis and reduction of bleeding episodes in hemophilia a and von willebrand disease.
Conditions treated with DDAVP
| Nephrogenic diabetes insipidus | Desmopressin 0.2-0.4 ug/kg PO/IV Q8-12 h, up to 6 months |
|---|---|
| Central diabetes insipidus | Desmopressin 0.05-0.3 ug/kg PO Q24 h, lifelong |
| Hemophilia A | Desmopressin 0.3-0.5 ug/kg IV/IM or PO Q6-8 h, for acute bleed or surgery |
Side effects of DDAVP
Common reactions DDAVP can cause
DDAVP can cause headache in some individuals. It may lead to facial flushing due to blood vessel dilation. Some people experience mild nausea or stomach upset. Swelling of the lips or tongue can occur in rare cases. Changes in taste perception have been reported. Dizziness or lightheadedness may appear after administration. Rarely, increased heart rate or palpitations may be observed.
Things you should be aware of before using DDAVP
Headache is one of the most frequently reported side effects of DDAVP. Flushing may occur as the body reacts to the medication. Nausea and mild abdominal discomfort are also observed in many patients. Some individuals experience dizziness or a feeling of lightheadedness. Elevated blood pressure can occasionally be recorded during treatment. These reactions are generally mild and transient.
Common reactions associated with DDAVP
- Hyponatremia
- Thrombocytopenia
- Flushing
- Headache
- Nausea
DDAVP is a highly effective, fast-acting medication that can dramatically reduce bleeding episodes and improve quality of life for patients with mild hemophilia a, von willebrand disease, or nocturnal enuresis, but it must be used judiciously and under close medical supervision. Because its effect peaks within 1-3 hours and lasts roughly 8-12 hours, timing the dose to match the highest-risk period (e.g., before surgery, intense physical activity, or long travel) is essential. Regular monitoring of plasma levels, kidney function, and fluid balance helps prevent over-use that could trigger hyponatremia or thrombosis. Patients should keep a clear dosing schedule, avoid missed doses, and always inform healthcare providers of any concurrent medications or health changes. Educating family members or caregivers on the signs of excessive dosing and emergency steps can further safeguard against complications. Finally, combining DDAVP therapy with appropriate replacement therapy for severe disease and lifestyle modifications (hydration management, injury prevention) maximizes benefit while minimizing risk.
Michael Francis Spigner, MD, NRP
: ABEM Certified, Board Certification, Emergency Medical Services, Emergency Medicine
Antony Awad, D.O., M.S.
: ABEM Certified, Emergency Medicine
Matthew Robert Lohse, M.D.
: ABEM Certified, Advanced Emergency Medicine Ultrasonography, Emergency Medicine, Focused Practice Designation, Ultrasonography, Ultrasound
Joshua M. McConkey, M.D.
: ABEM Certified, Board Certification, Emergency Medical Services, Emergency Medicine
Patrick B. Broderick, M.D.
: ABEM Certified, Emergency Medicine
| Shipping method | Delivery time | Price | |
| Airmail service Delivery | 14-21 days | 10$ | Tracking# available in 4 days |
| Trackable service Delivery | 9-14 days | 30$ | Tracking# available in 2 days |
- Shipping worldwide
- Confidentiality and anonymity guarantee
- Safe and secure
- Discrete looking packages
- Dispatch orders within 24 hours
- 100% success delivery